Intellectual Property India Publishes Patent Application for 'Inhibitors Of Enl/Af9 Yeats And Flt3' Filed by Bridge Medicines

MUMBAI, India, July 25 -- Intellectual Property India has published a patent application (202517025529 A) filed by Bridge Medicines, New York, on March 20, for 'inhibitors of enl/af9 yeats and flt3.'

Inventor(s) include Ladduwahetty, Tammy; Degorce, Sebastien, L.; and Vacca, Joseph, P.

The application for the patent was published on July 25, under issue no. 30/2025.

According to the abstract released by the Intellectual Property India: "Compounds and pharmaceutical compositions comprising compounds that inhibit ENL/AF9 YEATS and FLT3 are disclosed herein. Methods for suppressing oncogene expression in a cell, or for treating acute leukemias, using the compounds and pharmaceutical compositions comprising the compounds are also disclosed. ...